Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Front Public Health. 2023 Dec 13;11:1322480. doi: 10.3389/fpubh.2023.1322480. eCollection 2023.
Early detection of prediabetes and diabetes better prevents long-term health complications. FPG and HbA1c levels are some common laboratory tests utilized as tools to diagnose diabetes and prediabetes, but the agreement rate between these two diagnostic tests varies, which could lead to underdiagnosis and thus undertreatment. This study aimed to analyze the agreement rate between FPG and HbA1c, as well as the physicians' accuracy of using these results to make a prediabetes or diabetes diagnosis through ICD-10 coding at a tertiary care hospital in Bangkok, Thailand.
A cross-sectional descriptive study was conducted using secondary data collected in a tertiary hospital's check-up clinic from August 16, 2019 to June 30, 2022 to study the prevalence and diagnosis of diabetes and prediabetes, determined through FPG and HbA1c laboratory results. We analyzed the two laboratory tests' diagnosis agreement rate and the physicians' accuracy of diagnosing diabetes and prediabetes in ICD-10 coding using the FPG and HbA1c results.
Among 8,024 asymptomatic participants, the period prevalence diagnosed through laboratory results was 5.8% for diabetes and 19.8% for prediabetes. Diabetes and prediabetes prevalence based on laboratory data differs from that of ICD-10 coding data. Specifically, 79.6% of diabetes patients and 32.3% of prediabetes patients were coded using the ICD-10 coding system. 4,094 individuals had both FPG and HbA1c data. The agreement rate for diagnosing diabetes and prediabetes between the two laboratory results is 89.5%, with Kappa statistics of 0.58. Using only one of the two laboratory results would have missed a substantial number of patients.
Our findings highlight screening test discrepancies and underdiagnosis issues that impede diagnostic accuracy enhancement and refined patient management strategies. Early diagnoses of prediabetes and diabetes, especially before symptoms arise, could increase health consciousness in individuals, thereby enabling the implementation of lifestyle modifications and prevention of serious health complications. We emphasize the importance of diagnosing these conditions using both FPG and HbA1c, along with subsequent accurate ICD-10 coding. Even though some hospitals lack certified HbA1c testing, we suggest enhancing the availability of HbA1c testing, which could benefit many people in Thailand.:https://www.thaiclinicaltrials.org, identifier [TCTR20230824003].
早期发现糖尿病前期和糖尿病有助于预防长期健康并发症。空腹血糖(FPG)和糖化血红蛋白(HbA1c)水平是用于诊断糖尿病和糖尿病前期的常见实验室检测手段,但这两种诊断检测方法的一致性存在差异,这可能导致漏诊和治疗不足。本研究旨在分析 FPG 和 HbA1c 之间的一致性,并分析泰国曼谷一家三级保健医院的医生使用这些结果通过 ICD-10 编码进行糖尿病前期或糖尿病诊断的准确性。
本研究采用横断面描述性研究方法,利用 2019 年 8 月 16 日至 2022 年 6 月 30 日在一家三级医院体检诊所收集的二级数据,研究 FPG 和 HbA1c 实验室结果确定的糖尿病和糖尿病前期的患病率和诊断。我们分析了两种实验室检测方法的诊断一致性,并分析了医生根据 FPG 和 HbA1c 结果使用 ICD-10 编码诊断糖尿病和糖尿病前期的准确性。
在 8024 名无症状参与者中,通过实验室结果诊断的现患率为 5.8%的糖尿病和 19.8%的糖尿病前期。基于实验室数据的糖尿病和糖尿病前期患病率与 ICD-10 编码数据不同。具体来说,79.6%的糖尿病患者和 32.3%的糖尿病前期患者使用 ICD-10 编码系统进行编码。有 4094 人同时有 FPG 和 HbA1c 数据。两种实验室结果诊断糖尿病和糖尿病前期的一致性为 89.5%,Kappa 统计值为 0.58。仅使用两种实验室结果之一将遗漏大量患者。
我们的研究结果突出了筛查试验差异和诊断不足的问题,这些问题阻碍了诊断准确性的提高和患者管理策略的完善。早期诊断糖尿病前期和糖尿病,特别是在出现症状之前,可以提高个人的健康意识,从而促使他们改变生活方式,预防严重的健康并发症。我们强调使用 FPG 和 HbA1c 进行诊断的重要性,以及随后进行准确的 ICD-10 编码。尽管一些医院缺乏经过认证的 HbA1c 检测,但我们建议增加 HbA1c 检测的可用性,这将使泰国的许多人受益。